SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-010874
Filing Date
2024-04-03
Accepted
2024-04-03 16:15:21
Documents
18
Period of Report
2024-05-13

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A zvra20240303_def14a.htm   iXBRL DEF 14A 1234385
6 proxy1pic.jpg GRAPHIC 38792
7 proxy2pic.jpg GRAPHIC 38501
8 yw0d_zeropage1.jpg GRAPHIC 148952
9 yw0d_zeropage2.jpg GRAPHIC 170367
  Complete submission text file 0001437749-24-010874.txt   3005597

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zvra-20231231.xsd EX-101.SCH 10477
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20231231_def.xml EX-101.DEF 14804
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20231231_lab.xml EX-101.LAB 31232
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20231231_pre.xml EX-101.PRE 14867
21 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240303_def14a_htm.xml XML 144010
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36913 | Film No.: 24818888
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)